Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature

被引:30
作者
Butler, James S. [1 ]
Loh, Stewart N. [1 ]
机构
[1] SUNY Syracuse, Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA
关键词
cancer; mutation; aggregation; folding kinetics;
D O I
10.1110/ps.062324206
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 modulates a large number of cellular response pathways and is critical for the prevention of cancer. Wild-type p53, as well as tumorigenic mutants, exhibits the singular property of spontaneously losing DNA binding activity at 37 degrees C. To understand the molecular basis for this effect, we examine the folding mechanism of the p53 DNA binding domain (DBD) at elevated temperatures. Folding kinetics do not change appreciably from 5 degrees C to 35 degrees C. DBD therefore folds by the same two-channel mechanism at physiological temperature as it does at 10 degrees C. Unfolding rates, however, accelerate by 10,000-fold. Elevated temperatures thus dramatically increase the frequency of cycling between folded and unfolded states. The results suggest that function is lost because a fraction of molecules become trapped in misfolded conformations with each folding-unfolding cycle. In addition, at 37 degrees C, the equilibrium stabilities of the off-pathway species are predicted to rival that of the native state, particularly in the case of destabilized mutants. We propose that it is the presence of these misfolded species, which can aggregate in vitro and may be degraded in the cell, that leads to p53 inactivation.
引用
收藏
页码:2457 / 2465
页数:9
相关论文
共 34 条
[21]   The IARC TP53 database: New Online mutation analysis and recommendations to users [J].
Olivier, M ;
Eeles, R ;
Hollstein, M ;
Khan, MA ;
Harris, CC ;
Hainaut, P .
HUMAN MUTATION, 2002, 19 (06) :607-614
[22]  
Pace C. N., 1997, PROTEIN STRUCTURE PR
[23]  
PICKSLEY SM, 1992, ONCOGENE, V7, P1649
[24]   Characterization of the p53-rescue drug CP-31398 in vitro and in living cells [J].
Rippin, TM ;
Bykov, VJN ;
Freund, SMV ;
Selivanova, G ;
Wiman, KG ;
Fersht, AR .
ONCOGENE, 2002, 21 (14) :2119-2129
[25]   CRINEPT-TROSY NMR reveals p53 core domain bound in an unfolded form to the chaperone Hsp90 [J].
Rüdiger, S ;
Freund, SMV ;
Veprintsev, DB ;
Fersht, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) :11085-11090
[26]   Protein folding kinetics exhibit an Arrhenius temperature dependence when corrected for the temperature dependence of protein stability [J].
Scalley, ML ;
Baker, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10636-10640
[27]   Thermodynamic properties of an extremely rapid protein folding reaction [J].
Schindler, T ;
Schmid, FX .
BIOCHEMISTRY, 1996, 35 (51) :16833-16842
[28]  
STANHOPEBAKER P, 1994, J BIOL CHEM, V279, P33575
[29]   MUTANT CONFORMATION OF P53 - PRECISE EPITOPE MAPPING USING A FILAMENTOUS PHAGE EPITOPE LIBRARY [J].
STEPHEN, CW ;
LANE, DP .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 225 (03) :577-583
[30]   The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein [J].
Takimoto, R ;
Wang, WG ;
Dicker, DT ;
Rastinejad, F ;
Lyssikatos, J ;
El-Deiry, WS .
CANCER BIOLOGY & THERAPY, 2002, 1 (01) :47-55